Mark Egan
Plus aucun poste en cours
Profil
Mark Egan is Vice President of Operations for Sirna Therapeutics, Inc. He joined Sirna Therapeutics in 2001 and became Vice President of Manufacturing in December, 2003.
Dr. Egan began his career with ICI in 1990 and served as Manager of R&D Chemist and Business Project.
He received a degree in Chemistry in 1987 and a PhD in 1990 from the University of Glasgow.
Anciens postes connus de Mark Egan
| Sociétés | Poste | Fin |
|---|---|---|
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Directeur des opérations | 01/12/2006 |
ICI Group
 ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Corporate Officer/Principal | - |
Formation de Mark Egan
| University of Glasgow | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
ICI Group
ICI Group Industrial SpecialtiesProcess Industries ICI Group is a British company that manufactures paints and coatings. | Process Industries |
